Literature DB >> 1201618

Protein chain initiation in vitro by liver cell components from DMNA-treated rats.

O Nygård, T Hultin.   

Abstract

The mechanism of inhibition of protein synthesis in rat liver after dimethylnitrosamine (DMNA) administration was studied at the level of peptide-chain initiation by use of initiation-dependent amino acid incorporating systems. Ribosomal monomers, poly(A)-concontaining loss of acticity due to the DMNA treatment. The poly(A) RNA from monosomes and polysomes, and crude initiation factors from microsomes were prepared 2 h after a single dose of DMNA (75 mg/kg), and their activities in the production of new protein chains determined under conditions of nearly linear response. Monosomes and crude initiation factors from DMNA-treated rats were at least as active as those from controls. Preparations of poly(A)-containing RNA had a consistently higher template activity when prepared from polysomes instead of monosomes. However, in neither case was there any ltaining RNA was methylated by DMNA to about the same extent as the 18S and 28S rRNA. The methylation was consistently somewhat higher in the RNA preparations from monosomes than in those from polysomes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201618     DOI: 10.1016/0009-2797(75)90033-2

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  3 in total

1.  Protein synthesis inhibition induced by dimethylnitrosamine and diethylnitrosamine on isolated rat hepatocytes.

Authors:  E Mattei; A Delpino; U Ferrini
Journal:  Experientia       Date:  1979-09-15

2.  Preparation of projection-less particles from influenza virus and their messenger activities in prokaryotic and eukaryotic systems.

Authors:  E N Arida; T Hultin
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  Early effects of dimethylnitrosamine on the initiation of protein synthesis in mouse liver.

Authors:  O Nygård; T Hultin
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.